 |
|
Presage Biosciences Announces First Patient in Clinical Trial of CIVO™ Precision Oncology
April 19, 2013
| SEATTLE, Wash.
Presage Biosciences Announces Strategic Research Alliance with Celgene Corporation
March 5, 2013
| SEATTLE, Wash.
Device
Tests Drugs on a Tumor That's Still in the Body
January 16, 2013 | MIT Tech Review
About Us
Presage Biosciences is dedicated to improving the cancer drug development
process so that patients can receive the most effective treatment possible.
Our proprietary technology platform allows for the rapid, reliable assessment of multiple cancer therapeutics in an in vivo setting, providing the first side-by-side comparison of multiple drugs and drug combinations within a single living tumor.
